KKR (KKR) completed a $250 million investment in Henry Schein (HSIC) and holds a 12% stake in the health-care solution provider.
KKR's executive adviser, William Daniel, has joined Henry Schein's board in connection with the investment.
He joins Max Lin, a partner at KKR and leader of the firm's health care industry team in the Americas, who became a member of the board in early May, Henry Schein said Friday in a statement.